What is Lowe Syndrome

TL;DR: Lowe syndrome, also known as oculocerebrorenal syndrome, is a rare genetic disorder that primarily affects the eyes, brain, and kidneys. It is caused by mutations in the OCRL gene, which disrupts the normal development and function of these organ systems, leading to cataracts, intellectual disability, and renal tubular dysfunction.

What exactly is Lowe syndrome?

Lowe syndrome is a multisystemic disorder characterized by a specific triad of symptoms involving the eyes, the central nervous system, and the kidneys. Because it is a systemic condition, individuals with Lowe syndrome require a multidisciplinary medical approach to manage the various ways the body is affected. While it is a lifelong condition, targeted therapies can help manage the symptoms and improve the quality of life for those living with the diagnosis.

Which body systems are affected by Lowe syndrome?

Lowe syndrome impacts the body in several distinct ways. The primary areas of concern include:

• Eyes: Nearly all males with Lowe syndrome are born with bilateral cataracts, and many also experience glaucoma, which can lead to vision loss if not addressed early.


• Brain: The condition is associated with varying degrees of intellectual disability, behavioral challenges, and, in some cases, seizures.


• Kidneys: Patients typically develop Fanconi syndrome, a dysfunction of the renal tubules that causes the body to lose essential nutrients like bicarbonate, amino acids, and phosphate in the urine.


• Musculoskeletal System: Many individuals experience low muscle tone (hypotonia) in infancy, joint issues, and a risk of bone fractures due to the underlying kidney imbalances.

How common is Lowe syndrome and who does it affect?

Lowe syndrome is an ultra-rare condition. It is estimated to affect approximately 1 in 500,000 people, though the exact prevalence is difficult to determine due to potential underdiagnosis. Because the gene responsible for Lowe syndrome is located on the X chromosome, it almost exclusively affects males. Females are typically carriers and generally do not show symptoms, although they may occasionally exhibit mild eye findings like small cataracts.

What causes Lowe syndrome at the genetic level?

The underlying cause of Lowe syndrome is a mutation in the OCRL gene. This gene provides instructions for creating an enzyme that plays a critical role in the processing of fats and proteins within the cell membrane. When this enzyme is not functioning correctly, essential cellular processes are disrupted, particularly in the tissues of the eyes, brain, and kidneys. This genetic mechanism is why the symptoms of Lowe syndrome are so specific to these three areas of the body.

How is Lowe syndrome different from other conditions?

While many genetic syndromes involve intellectual disability or kidney issues, the specific combination of congenital cataracts, Fanconi-type renal tubule dysfunction, and hypotonia in a male infant is the hallmark of Lowe syndrome. Unlike some metabolic disorders, this condition is not typically associated with progressive neurodegeneration, though the developmental delays are usually present from birth.

Next steps

• Consult a clinical geneticist to confirm the diagnosis through OCRL gene sequencing.


• Establish care with a team of specialists, including a pediatric ophthalmologist, a nephrologist, and a neurologist.


• Connect with the DiseaseMaps.org community to share experiences and find support from others navigating rare disease journeys.


• Review resources from the Lowe Syndrome Association for the latest clinical trial information and patient registries.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Oculocerebrorenal syndrome (ORPHA:527)


• NIH Genetic and Rare Diseases Information Center (GARD): Lowe Syndrome


• OMIM (Online Mendelian Inheritance in Man): Lowe Oculocerebrorenal Syndrome (#309000)


• Lowe Syndrome Association (LSA)